Long-term efficacy of the complement inhibitor eculizumab in cold agglutinin disease.
Röth
Alexander
A
Hüttmann
Andreas
A
Rother
Russell P
RP
Dührsen
Ulrich
U
Philipp
Thomas
T
D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000097:blood / Q000188:drug therapy*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D051056:Complement Inactivating Agents / Q000008:administration & dosage*; D003165:Complement System Proteins; D006801:Humans; D007075:Immunoglobulin M / Q000097:blood; D008297:Male; D012074:Remission Induction; D013997:Time Factors
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D051056:Complement Inactivating Agents; D007075:Immunoglobulin M; D003165:Complement System Proteins; C481642:eculizumab